Kalkunte S. Srivenugopal, PhD (Venu) is a tenured Professor in the Department of Biomedical Sciences at Texas Tech University Health Sciences Center School of Pharmacy. He joined in September 2002. Dr. Venu received his Ph.D. in Biochemistry from the Indian Institute of Science, Bangalore, India in 1981. Following postdoctoral training at the University of Washington, , he held faculty positions at the Rosalind Franklin University of Medicine and science, University of Medicine and Dentistry of New Jersey and the University of Texas M.D. Anderson Cancer Center before joining the Texas Tech HSC. Dr. Srivenugopal’s research interests include the anticancer drug resistance focusing on the DNA-repair O6-methylguanine-DNA methyltransferase (MGMT), redox stress in cancers and regulation of p53 function. He has been funded in the past by the American Cancer Society, NIH (R29, RO1 and RO3 grants) and currently from the Cancer Prevention and Research Institute of Texas.